- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic therapies in hepatocellular carcinoma: present and future
Authors
Keywords
-
Journal
Future Oncology
Volume 9, Issue 10, Pages 1533-1548
Publisher
Future Medicine Ltd
Online
2013-10-09
DOI
10.2217/fon.13.171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance development after long-term sorafenib exposure in hepatocellular cancer cell lines and risk of rebound growth and epithelial to mesenchymal transition.
- (2017) Chris Verslype et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
- (2013) A Santoro et al. BRITISH JOURNAL OF CANCER
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Serum Markers of Intrahepatic Cholangiocarcinoma
- (2013) Giulia Malaguarnera et al. DISEASE MARKERS
- Transarterial chemoembolization of hepatocellular carcinoma – agents and drugs: an overview. Part 2
- (2013) Paolo Giunchedi et al. Expert Opinion on Drug Delivery
- Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers
- (2013) Monica Dandona Desai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: Effect of patient and nonpatient factors
- (2013) Jessica A. Davila et al. HEPATOLOGY
- Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
- (2013) Martin Franz Sprinzl et al. HEPATOLOGY
- Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy
- (2013) Koji Teramoto et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
- (2012) Han Chong Toh et al. CANCER
- Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
- (2012) R. S. Finn et al. CLINICAL CANCER RESEARCH
- Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice
- (2012) Giovan Giuseppe Di Costanzo et al. DIGESTIVE AND LIVER DISEASE
- Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma
- (2012) Fei Zhao et al. DIGESTIVE DISEASES
- Cellular Immune Responses to Hepatocellular Carcinoma: Lessons for Immunotherapy
- (2012) Nathalie Schmidt et al. DIGESTIVE DISEASES
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma
- (2012) Cedo Martin Bagi et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Current practice of chronic hepatitis B treatment in Southern Italy
- (2012) T. Stroffolini et al. European Journal of Internal Medicine
- Tivantinib in hepatocellular carcinoma
- (2012) Jörg Trojan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Brivanib: a review of development
- (2012) Tina Chou et al. Future Oncology
- Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease
- (2012) Thomas Yau et al. INVESTIGATIONAL NEW DRUGS
- Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
- (2012) Mervat El Ansary et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Risk stratification for hepatitis B virus related hepatocellular carcinoma
- (2012) Chih-Lin Lin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- (2012) György Baffy et al. JOURNAL OF HEPATOLOGY
- Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II
- (2012) Can Huang et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial
- (2012) A.O. Kaseb et al. ONCOLOGY
- Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials
- (2012) Ping Fang et al. PLoS One
- Molecular Targeted Therapies in Hepatocellular Carcinoma
- (2012) Shinji Tanaka et al. SEMINARS IN ONCOLOGY
- Hepatocellualar Carcinoma Serum Markers
- (2012) Gaetano Bertino et al. SEMINARS IN ONCOLOGY
- Elevated serum levels of Chromogranin A in hepatocellular carcinoma
- (2012) Antonio Biondi et al. BMC Surgery
- Immunotherapy of hepatocellular carcinoma
- (2012) Angela D. Pardee et al. OncoImmunology
- Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma
- (2011) Weijing Sun et al. CANCER
- Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
- (2011) Philip A. Philip et al. CANCER
- Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation
- (2011) H. Huynh et al. CURRENT CANCER DRUG TARGETS
- Erratum
- (2011) Future Oncology
- Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion
- (2011) Danijela Petrovic et al. HEPATOLOGY
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review
- (2011) J.-H. Zhong et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatitis B virus X gene and hepatocarcinogenesis
- (2011) Sue-Ann Ng et al. JOURNAL OF GASTROENTEROLOGY
- Breast Cancer-Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown
- (2011) S. Previdi et al. MOLECULAR CANCER THERAPEUTICS
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes
- (2011) Joel M. O'Bryan et al. PLoS One
- Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
- (2010) C-H Hsu et al. BRITISH JOURNAL OF CANCER
- A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment
- (2010) A. D. Pardee et al. CANCER RESEARCH
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps
- (2010) Augusto Villanueva et al. CURRENT OPINION IN ONCOLOGY
- Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response
- (2010) Céline Miroux et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells
- (2010) Mei-Chuan Chen et al. HEPATOLOGY
- Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma
- (2010) Ghassan K. Abou-Alfa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
- (2010) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
- (2010) Chih-Hung Hsu et al. JOURNAL OF HEPATOLOGY
- Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice
- (2010) H. Kayashima et al. JOURNAL OF IMMUNOLOGY
- ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
- (2010) N. Munshi et al. MOLECULAR CANCER THERAPEUTICS
- Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen
- (2010) Stéphanie Becker et al. NUCLEAR MEDICINE AND BIOLOGY
- Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
- (2010) Marcus Alexander Wörns et al. ONCOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?
- (2009) Andrew X Zhu BMC Medicine
- Systemic Therapies in Hepatocellular Carcinoma
- (2009) Marcus Alexander Wörns et al. DIGESTIVE DISEASES
- Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
- (2009) Leen Delang et al. HEPATOLOGY
- Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
- (2009) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of hepatocellular carcinoma in Japan
- (2009) Takeji Umemura et al. JOURNAL OF GASTROENTEROLOGY
- Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population
- (2008) Thomas Yau et al. CANCER
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics
- (2008) C. Verhoef et al. DIGESTIVE SURGERY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel advancements in the management of hepatocellular carcinoma in 2008
- (2008) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas
- (2008) Wenhua Piao et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of systemic therapy of advanced hepatocellular carcinoma
- (2008) Thomas Yau et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Combination of radiofrequency ablation and immunotherapy
- (2007) Francesco et al. Frontiers in Bioscience-Landmark
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started